Skip to main content
Log in

Proliferative Activity of Colorectal Cancer Cells with Different Levels of CD133 Expression

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied proliferative activity of colorectal cancer cells with different expression level of CD133 molecule associated with cancer stem cells phenotype. Analysis of BrdU incorporation into Caco-2 and HT-29 cell lines showed that the percentage of cells in the DNA synthesis phase in the CD133+/high population is higher than in CD133—/low population. The expression of proliferation marker Ki-67 and the percentage of Ki-67+ cells were also higher in the CD133+/high population. Colorimetric analysis with crystal violet dye showed that the number of cells after 10-days culturing was higher in the CD133+/high population in both cell lines. These findings suggest that cells with high level of CD133 expression are characterized by higher proliferative activity, which can contribute to the tumor progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Suvorov RE, Kim YS, Gisina AM, Chiang JH, Yarygin KN, Lupatov AY. Surface Molecular Markers of Cancer Stem Cells: Computation Analysis of Full-Text Scientific Articles. Bull. Exp. Biol. Med. 2018;166(1):135-140.

    Article  CAS  Google Scholar 

  2. Batlle E, Clevers H. Cancer stem cells revisited. Nat. Med.2017; 23(10):1124-1134.

    Article  CAS  Google Scholar 

  3. Chang PH, Sekine K, Chao HM, Hsu SH, Chern E. Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells. Sci. Rep. 2017;8. ID 45751. doi: https://doi.org/10.1038/srep45751

  4. Corbeil D, Röper K, Fargeas C.A, Joester A, Huttner W.B. Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic. 2001;2(2):82-91.

    Article  CAS  Google Scholar 

  5. Glumac PM, LeBeau AM. The role of CD133 in cancer: a concise review. Clin. Transl. Med. 2018;7(1):18. doi: https://doi.org/10.1186/s40169-018-0198-1.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Jang JW, Song Y, Kim SH, Kim J, Seo HR. Potential mechanisms of CD133 in cancer stem cells. Life Sci. 2017;184:25-29.

    Article  CAS  Google Scholar 

  7. Kim YS, Kaidina AM, Chiang JH, Yarygin KN, Lupatov AY. Cancer stem cell molecular markers verified in vivo. Biomed. Khim. 2016;62(3):228-238.

    Article  CAS  Google Scholar 

  8. Mak AB, Nixon AM, Kittanakom S, Stewart JM, Chen GI, Curak J, Gingras AC, Mazitschek R, Neel BG, Stagljar I, Moffat J. Regulation of CD133 by HDAC6 promotes β-catenin signaling to suppress cancer cell differentiation. Cell Rep. 2012;2(4):951-963.

    Article  CAS  Google Scholar 

  9. Röper K, Corbeil D, Huttner WB. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat. Cell Biol. 2000;2(9):582-592.

    Article  Google Scholar 

  10. Zacchigna S, Oh H, Wilsch-Bräuninger M, Missol-Kolka E, Jászai J, Jansen S, Tanimoto N, Tonagel F, Seeliger M, Huttner WB, Corbeil D, Dewerchin M, Vinckier S, Moons L, Carmeliet P. Loss of the cholesterol-binding protein prominin-1/CD133 causes disk dysmorphogenesis and photoreceptor degeneration. J. Neurosci. 2009;29(7):2297-2308.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. M. Gisina.

Additional information

Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 2, pp. 84-89, June, 2019

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gisina, A.M., Kim, Y.S., Potashnikova, D.M. et al. Proliferative Activity of Colorectal Cancer Cells with Different Levels of CD133 Expression. Bull Exp Biol Med 167, 541–545 (2019). https://doi.org/10.1007/s10517-019-04569-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-019-04569-y

Key Words

Navigation